These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32584134)

  • 1. Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis.
    Bubová K; Prajzlerová K; Hulejová H; Gregová M; Mintálová K; Hušáková M; Forejtová Š; Filková M; Tomčík M; Vencovský J; Pavelka K; Šenolt L
    Physiol Res; 2020 Aug; 69(4):653-660. PubMed ID: 32584134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis.
    Prajzlerová K; Grobelná K; Hušáková M; Forejtová Š; Jüngel A; Gay S; Vencovský J; Pavelka K; Šenolt L; Filková M
    PLoS One; 2017; 12(9):e0185323. PubMed ID: 28938006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Serum Levels of Sclerostin are Associated with High Disease Activity and Functional Impairment in Patients with Axial Spondyloarthritis.
    Muntean L; Lungu A; Gheorghe SR; Valeanu M; Craciun AM; Felea I; Petcu A; Filipescu I; Simon SP; Rednic S
    Clin Lab; 2016; 62(4):589-97. PubMed ID: 27215077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.
    Danve A; Reddy A; Vakil-Gilani K; Garg N; Dinno A; Deodhar A
    Clin Rheumatol; 2015 Jan; 34(1):117-24. PubMed ID: 25421013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis.
    Siebuhr AS; Hušaková M; Forejtová S; Zegzulková K; Tomčik M; Urbanová M; Grobelná K; Gatterová J; Bay-Jensen AC; Pavelka K
    Clin Exp Rheumatol; 2019; 37(3):358-366. PubMed ID: 30767876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of non-radiographic axial spondyloarthritis.
    Boonen A; Sieper J; van der Heijde D; Dougados M; Bukowski JF; Valluri S; Vlahos B; Kotak S
    Semin Arthritis Rheum; 2015 Apr; 44(5):556-562. PubMed ID: 25532945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study.
    Hulejová H; Kropáčková T; Bubová K; Kryštůfková O; Filková M; Mann H; Forejtová Š; Tomčík M; Vencovský J; Pavelka K; Šenolt L
    Rheumatol Int; 2019 Jun; 39(6):1037-1043. PubMed ID: 31025138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis.
    Rubio Vargas R; Melguizo Madrid E; González Rodríguez C; Navarro Sarabia F; Dominguez Quesada C; Ariza Ariza R; Navarro Compán V
    Reumatol Clin; 2017; 13(4):197-200. PubMed ID: 27297260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis.
    López-Medina C; Ramiro S; van der Heijde D; Sieper J; Dougados M; Molto A
    RMD Open; 2019; 5(2):e001108. PubMed ID: 31803500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study.
    Lorenzin M; Ortolan A; Vio S; Favero M; Oliviero F; Zaninotto M; Cosma C; Lacognata C; Punzi L; Ramonda R
    Reumatismo; 2017 Aug; 69(2):65-74. PubMed ID: 28776360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis.
    Gupta L; Bhattacharya S; Aggarwal A
    Clin Rheumatol; 2018 May; 37(5):1401-1405. PubMed ID: 29313272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
    Olofsson T; Lindqvist E; Mogard E; Andréasson K; Marsal J; Geijer M; Kristensen LE; Wallman JK
    Rheumatology (Oxford); 2019 Jul; 58(7):1176-1187. PubMed ID: 30649509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
    Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
    Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.